{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:02:04Z","timestamp":1784523724127,"version":"3.55.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer is the second most commonly diagnosed malignancy among men worldwide. Its biological heterogeneity challenges conventional imaging-based risk assessment and complicates biopsy decision-making. Although advanced artificial intelligence may improve risk stratification, medical imaging applications are often limited by small sample sizes. Vision foundation models, with strong transferability in data-constrained settings, offer a promising approach to improving prostate cancer risk assessment, guiding personalized treatment, and reducing overdiagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A robust transfer learning framework based on prostate magnetic resonance imaging (MRI), termed robust transfer learning model (RTLM), was developed to enable the non-invasive risk assessment of clinically significant prostate cancer (csPCa). RTLM employs a feature-matching transfer strategy to adaptively capture task-relevant abstract knowledge from vision foundation models, thereby enhancing the feature representation capability and robustness of convolutional neural networks. Model performance was evaluated on csPCa MRI data, and a multi-task evaluation was conducted on PD-L1 expression prediction in patients with non-small cell lung cancer (NSCLC) to assess the generalizability of the proposed framework. Subsequently, features extracted by the RTLM were used to construct a deep learning signature (DLS), which was then integrated with key clinical variables, including age, serum total PSA level, PSA density, prostate volume, and PI-RADS score, to build the clinical-imaging fusion model (CIFM) for csPCa risk assessment. Diagnostic performance was evaluated using the area under the curve (AUC), decision curve analysis (DCA), integrated discrimination improvement (IDI), and net reclassification improvement (NRI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The CIFM achieved AUCs of 0.918, 0.890, 0.828, and 0.852 in the training cohort (n = 585), test cohort (n = 310), and two external validation cohorts (n = 510 and n = 94), respectively. Compared with the clinical model and the RTLM, CIFM showed significant improvements in both IDI and NRI (all p &amp;lt; 0.05). Decision curve analysis further demonstrated that CIFM provided greater net clinical benefit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>By effectively leveraging knowledge representations from vision foundation models, RTLM enhances the feature learning capability and robustness of CNNs in small-sample medical imaging tasks. The CIFM, which integrates clinical indicators, demonstrates good accuracy in csPCa risk assessment, suggesting potential generalizability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1844810","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:20:42Z","timestamp":1784521242000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical-imaging fusion model for risk assessment of clinically significant prostate cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuyao","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Medical Imaging, Nanxishan Hospital of Guangxi Zhuang Autonomous Region","place":["Gulin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaole","family":"Yu","sequence":"additional","affiliation":[{"name":"Laboratory of Intelligent Detection and Information Processing, Guilin University of Aerospace Technology","place":["Guilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[{"name":"Laboratory of Intelligent Detection and Information Processing, Guilin University of Aerospace Technology","place":["Guilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Kang","sequence":"additional","affiliation":[{"name":"Laboratory of Intelligent Detection and Information Processing, Guilin University of Aerospace Technology","place":["Guilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuke","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Affiliated Cancer Hospital of Guangxi Medical University and Cancer Institute of Guangxi Zhuang Autonomous Region","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[{"name":"Laboratory of Intelligent Detection and Information Processing, Guilin University of Aerospace Technology","place":["Guilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunde","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory of Intelligent Detection and Information Processing, Guilin University of Aerospace Technology","place":["Guilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghui","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Computer Science and Engineering, Guilin University of Aerospace Technology","place":["Guilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Feng","sequence":"additional","affiliation":[{"name":"Laboratory of Intelligent Detection and Information Processing, Guilin University of Aerospace Technology","place":["Guilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengmin","family":"Liu","sequence":"additional","affiliation":[{"name":"Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/his.13712","article-title":"Defining clinically significant prostate cancer on the basis of pathological findings","volume":"74","author":"Matoso","year":"2019","journal-title":"Histopathology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"Jama"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.7589","article-title":"Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial","volume":"7","author":"Klotz","year":"2021","journal-title":"JAMA Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1148\/radiol.2020190646","article-title":"Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel","volume":"296","author":"Westphalen","year":"2020","journal-title":"Radiology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/jmri.26555","article-title":"Intra- and interreader reproducibility of PI-RADSv2: a multireader study","volume":"49","author":"Smith","year":"2019","journal-title":"Journal of Magnetic Resonance Imaging"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.11.031","article-title":"Detection of individual prostate cancer foci via multiparametric magnetic resonance imaging","volume":"75","author":"Johnson","year":"2019","journal-title":"Eur Urol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41746-021-00438-z","article-title":"Diagnostic accuracy of deep learning in medical imaging: a systematic review and meta-analysis","volume":"4","author":"Aggarwal","year":"2021","journal-title":"NPJ Digital Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1038\/s41591-024-03139-8","article-title":"Integrated image-based deep learning and language models for primary diabetes care","volume":"30","author":"Li","year":"2024","journal-title":"Nature Medicine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-10074-8","article-title":"Effects of a comprehensive brain computed tomography deep learning model on radiologist detection accuracy","volume":"34","author":"Buchlak","year":"2024","journal-title":"Eur Radio"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-06036-9","article-title":"Predicting clinically significant prostate cancer with a deep learning approach: a multicentre retrospective study","volume":"50","author":"Zhao","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2024.08.028","article-title":"Deep learning model for pathological grading and prognostic assessment of lung cancer using CT imaging: a study on NLST and external validation cohorts","volume":"32","author":"Yang","year":"2025","journal-title":"Acad Radiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002683","article-title":"Variable generalization performance of a deep learning model to detect pneumonia in chest radiographs: a cross-sectional study","volume":"15","author":"Zech","year":"2018","journal-title":"PloS Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.engappai.2025.110519","article-title":"Enhancing histopathological image analysis: an explainable vision transformer approach with comprehensive interpretation methods and evaluation of explanation quality","volume":"149","author":"Mir","year":"2025","journal-title":"Eng Appl Artif Intell"},{"key":"B16","first-page":"39","article-title":"Exploring explainable AI in brain tumor detection: a hybrid approach using EfficientNet and CBAM","volume-title":"DICCT 2025: Proceedings of the 3rd International Conference on Device Intelligence, Computing and Communication Technologies","author":"Mir","year":"2025"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2304.07193","article-title":"Dinov2: learning robust visual features without supervision","author":"Oquab","year":"2023","journal-title":"arXiv Preprint arXiv:230407193"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvcir.2021.103145","article-title":"Rethinking pre-training on medical imaging","volume":"78","author":"Wen","year":"2021","journal-title":"J Visual Commun Image Represent"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1109\/CVPR.2019.01155","article-title":"Characterizing and avoiding negative transfer","author":"Wang","year":"2019"},{"key":"B20","article-title":"Learning what and where to transfer","author":"Jang","year":"2019"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(24)00220-1","article-title":"Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study","volume":"25","author":"Saha","year":"2024","journal-title":"Lancet Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7937\/TCIA.2020.A61IOC1A","article-title":"Prostate MRI and ultrasound with pathology and coordinates of tracked biopsy (Prostate-MRI-US-biopsy) [DS]","author":"Natarajan","year":"2020","journal-title":"The Cancer Imaging Archive."},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1109\/CVPR.2016.90","article-title":"Deep residual learning for image recognition","author":"He","year":"2016"},{"key":"B25","first-page":"360","article-title":"Incorporating clinical guidelines through adapting multi-modal large language model for prostate cancer PI-RADS scoring","volume-title":"Lecture Notes in Computer Science","author":"Zhang","year":"2024"},{"key":"B26","doi-asserted-by":"publisher","first-page":"102510","DOI":"10.1016\/j.compmedimag.2025.102510","article-title":"Z-SSMNet: zonal-aware self-supervised mesh network for prostate cancer detection and diagnosis with bi-parametric MRI","volume":"122","author":"Yuan","year":"2025","journal-title":"Comput Med Imaging Graphics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5667","article-title":"A magnetic resonance imaging-based prediction model for prostate biopsy risk stratification","volume":"4","author":"Mehralivand","year":"2018","journal-title":"JAMA Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.07.022","article-title":"Predicting the need for biopsy to detect clinically significant prostate cancer in patients with a magnetic resonance imaging\u2013detected Prostate Imaging Reporting and Data System\/Likert \u22653 lesion: development and multinational external validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score","volume":"82","author":"Peters","year":"2022","journal-title":"Eur Urol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1844810\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:20:43Z","timestamp":1784521243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1844810\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":28,"alternative-id":["10.3389\/fonc.2026.1844810"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1844810","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"article-number":"1844810"}}